Insider · CIK 0001732197

LaRocca John

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001732197

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-16	Y-mAbs Therapeutics, Inc.D Disposition to Issuer	SVP, General Counsel & Secry	DDisposition to Issuer	−21.5K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	SVP, General Counsel & Secry	DDisposition to Issuer	−143K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	SVP, General Counsel & Secry	DDisposition to Issuer	−42.9K sh	—	—	0
2025-01-17	Y-mAbs Therapeutics, Inc.A Award	SVP, General Counsel & Secry	AAward	+21.5K sh	—	—	21,500
2025-01-17	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	SVP, General Counsel & Secry	AAward	+42.9K sh	—	—	42,900
2022-11-21	AERIE PHARMACEUTICALS INCD Disposition to Issuer	General Counsel	DDisposition to Issuer	−53.6K sh	$15.25	−$817K	0
2022-11-21	AERIE PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−65.9K sh	$6.45	−$425K	0
2022-08-14	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−771 sh	$11.57	−$8,920.47	53,585
2022-03-18	AERIE PHARMACEUTICALS INCA Award	General Counsel	AAward	+19K sh	—	—	54,356
2022-03-18	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	General Counsel	AAward	+65.9K sh	—	—	65,941
2022-02-19	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−1,973 sh	$6.00	−$11.8K	35,341
2022-02-07	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−768 sh	$7.24	−$5,560.32	37,314
2022-02-06	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−384 sh	$7.05	−$2,707.2	38,082
2022-02-04	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−1,206 sh	$7.05	−$8,502.3	38,466
2021-08-14	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−765 sh	$14.70	−$11.2K	39,672
2021-02-19	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−1,542 sh	$15.95	−$24.6K	40,437
2021-02-07	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−706 sh	$17.68	−$12.5K	41,979
2021-02-06	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−353 sh	$17.68	−$6,241.04	42,685
2021-02-04	AERIE PHARMACEUTICALS INCA Award	General Counsel	AAward	+11K sh	—	—	43,038
2021-02-04	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	General Counsel	AAward	+50K sh	—	—	50,000
2020-08-14	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−685 sh	$12.71	−$8,706.35	32,038
2020-02-19	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−1,542 sh	$19.47	−$30K	32,723
2020-02-07	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−693 sh	$20.49	−$14.2K	34,265
2020-02-06	AERIE PHARMACEUTICALS INCA Award	General Counsel	AAward	+3,500 sh	—	—	34,958
2020-02-06	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	General Counsel	AAward	+15.5K sh	—	—	15,500
2019-08-14	AERIE PHARMACEUTICALS INCA Award	General Counsel	AAward	+8,000 sh	—	—	31,458
2019-08-14	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	General Counsel	AAward	+36K sh	—	—	36,000
2019-02-19	AERIE PHARMACEUTICALS INCF Tax Payment	General Counsel	FTax Payment	−1,542 sh	$40.80	−$62.9K	23,458
2019-02-07	AERIE PHARMACEUTICALS INCA Award	General Counsel	AAward	+7,000 sh	—	—	25,000
2019-02-07	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	General Counsel	AAward	+31K sh	—	—	31,000
2018-02-19	AERIE PHARMACEUTICALS INCA Award	General Counsel	AAward	+18K sh	—	—	18,000
2018-02-19	AERIE PHARMACEUTICALS INCStock Option (Right to Buy)A Award	General Counsel	AAward	+70K sh	—	—	70,000

Recent filings

Accepted (ET)
Sep 184
LaRocca John0001732197-25-000005
SEC(opens sec.gov)
Jan 224
LaRocca John0001415889-25-001874
SEC(opens sec.gov)
Nov 214
LaRocca John0001209191-22-058180
SEC(opens sec.gov)
Aug 164
LaRocca John0001209191-22-045976
SEC(opens sec.gov)
Mar 224
LaRocca John0001209191-22-020655
SEC(opens sec.gov)
Feb 234
LaRocca John0001209191-22-012251
SEC(opens sec.gov)
Feb 94
LaRocca John0001209191-22-008228
SEC(opens sec.gov)
Feb 84
LaRocca John0001209191-22-007897
SEC(opens sec.gov)
Aug 174
LaRocca John0001209191-21-051897
SEC(opens sec.gov)
Feb 234
LaRocca John0001209191-21-013224
SEC(opens sec.gov)
Feb 94
LaRocca John0001209191-21-009020
SEC(opens sec.gov)
Feb 84
LaRocca John0001209191-21-008584
SEC(opens sec.gov)

Companies

Address

C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE

NEW YORK, NY, 10169